Literature DB >> 3261207

Memory B cells express a phenotype consistent with migratory competence after secondary but not short-term primary immunization.

G Kraal1, I L Weissman, E C Butcher.   

Abstract

The cell surface phenotype of dinitrophenol (DNP)-specific memory B cells, defined by their capacity to transfer IgG responses into syngeneic irradiated recipients, was assessed using two markers of relevance to lymphocyte migratory properties: (i) peanut agglutinin, which binds to terminal galactosyl residues expressed at high levels by several nonmigrating lymphocyte subsets and, among lymph node B cells, is highly specific for germinal center cells; and (ii) MEL-14, a monoclonal antibody specific for lymphocyte surface receptors required for migration from the blood into peripheral lymph nodes. At various times after primary or secondary immunization with DNP-keyhole limpet hemocyananin (KLH), lymph node B cells were separated by fluorescence-activated cell sorting on the basis of staining with PNA and/or MEL-14, and the presence of B-memory cells in each fraction was assessed by adoptive transfer with antigen (DNP-KLH) and helper T cells. One week after immunization, most of the memory sorted in the PNAhi population, confirming a previous report by R. F. Coico, B. S. Bhogal, and G. J. Thorbecke (J. Immunol. 131, 2254, 1983) that early memory B cells or their precursors are contained within the germinal center cell population, a population which is known to be MEL-14- and migratory-incompetent. Six weeks after primary stimulation, however, the bulk of memory cells, unlike germinal center cells, were MEL-14hi. After secondary immunization, memory was still predominantly MEL-14+ and PNAlo, although in some experiments adoptive responses were transferred by all sorted fractions. The results are consistent with the hypothesis that antigen-specific B cells initially undergo local (sessile) differentiation and proliferation in germinal centers, where they develop the capacity for adoptive transfer of antigen-specific secondary responses, but that with continued development their long-lived memory-containing progeny express a phenotype permitting their reentry into the recirculating lymphocyte pool.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261207     DOI: 10.1016/0008-8749(88)90163-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Responses of single germinal-center B cells in T-cell-dependent microculture.

Authors:  A George; J J Cebra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

2.  Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.

Authors:  M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Differential regulation of leucocyte L-selectin (CD62L) expression in normal lymphoid and inflamed extralymphoid tissues.

Authors:  J M Munro; D M Briscoe; T F Tedder
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 4.  B lymphocyte ontogeny and immunoglobulin production.

Authors:  F Hentges
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Interferon-gamma-increased adherence of lymphocytes to high endothelial venules.

Authors:  H R Hendriks; C Korn; R E Mebius; G Kraal
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

6.  Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation.

Authors:  Deepta Bhattacharya; Ming T Cheah; Christopher B Franco; Naoki Hosen; Christopher L Pin; William C Sha; Irving L Weissman
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

7.  Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.

Authors:  R Luque; J A Brieva; A Moreno; A Manzanal; L Escribano; J Villarrubia; J L Velasco; J López-Jiménez; C Cerveró; M J Otero; J Martínez; C Bellas; E Roldán
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.